Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD (COPD-OMA)

NCT07059091 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT07059091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07059091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD (COPD-OMA)
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Recruiting
Start date
February 12, 2026
Completion date
May 31, 2031
Enrollment
334 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

allergies, chronic obstructive pulmonary disease (copd)